IVD Medical Holding (HKSE:01931) ROCE % : 10.66% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is IVD Medical Holding ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IVD Medical Holding's annualized ROCE % for the quarter that ended in Dec. 2023 was 10.66%.

IVD Medical Holding ROCE % Historical Data

The historical data trend for IVD Medical Holding's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IVD Medical Holding ROCE % Chart

IVD Medical Holding Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

15.24

8.47

9.12

10.26

IVD Medical Holding Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial									10.21	6.69	11.23	10.12	10.66

IVD Medical Holding ROCE % Calculation

IVD Medical Holding's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	394.164	/	( ( (4817.817 - 1055.479)	+	(5233.789 - 1311.574) )	/ 2 )
	=	394.164	/	( (3762.338	+	3922.215)	/ 2 )
	=	394.164	/	3842.2765
	=	10.26 %

IVD Medical Holding's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	408.462	/	( ( (4980.713 - 1239.262)	+	(5233.789 - 1311.574) )	/ 2 )
	=	408.462	/	( ( 3741.451	+	3922.215 )	/ 2 )
	=	408.462	/	3831.833
	=	10.66 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

IVD Medical Holding (HKSE:01931) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IVD Medical Holding ROCE % Related Terms

Thank you for viewing the detailed overview of IVD Medical Holding's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

IVD Medical Holding (HKSE:01931) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » IVD Medical Holding Ltd (HKSE:01931) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 299, Bisheng Road, Room 602, Building 6, Zhangjiang Hi-Tech Park, Pudong New Area District, Shanghai, CHN

Website

http://www.ivdholding.com

IVD Medical Holding Ltd is principally engaged in the sale and manufacture of medical equipment and consumables and the provision of consultancy and maintenance services related to medical equipment. It has three segments. The distribution business, which is the key revenue driver, involves the trading of IVD analysers, reagents, and other consumables to customers such as distributors, hospitals and healthcare institutions, and logistics providers. The After-sales Services provided by Vastec include maintenance and repair services, installation services and end-customer training. Its Self-branded Products Business, distributes its self-developed IVD products under its own brand which includes IVD analysers and reagents under the IVD testing category of Point-of-care testing.

IVD Medical Holding (HKSE:01931) Headlines

No Headlines